Cascadia Capital Advises Bluebird Botanicals in Acquiring Precision Botanicals and Received a Growth Investment from Juggernaut Capital Partners

Bluebird Botanicals has acquired Precision Botanicals Logo and received a growth equity investment from Juggernaut Capital Partners Logo

Cascadia Capital, an investment bank serving middle market clients globally, is pleased to announce that its client, Bluebird Botanicals (“Bluebird”), a leading manufacturer and distributor of high-quality, branded hemp CBD products, has announced the acquisition of Precision Botanical, a science-driven CBD brand that is committed to providing purity, accuracy, and transparency for all of its CBD products. The combined company will have the resources and expertise to continue producing and delivering to customers the safest, highest-quality, and most effective botanical supplements nature can provide.

Operating as one of the oldest, largest, and most recognizable CBD brands, Bluebird offers multiple CBD products including its award-winning Classic CBD Oil and alternative options such as CBD isolates and CBD gummies. With the closing of this acquisition, Bluebird continues to demonstrate its leadership in the large and fast-growing CBD industry. The merger with Precision will allow Bluebird to strengthen its supply chain, continue to adhere to a rigorous hemp extraction process for all of its products, and further establish the combined company’s brand reputation for purity, safety, and quality among retailers and consumers.

Bluebird also gains instant access to Precision’s Oregon-based hemp cultivation and extraction facility. The combined company will benefit from Precision’s key science, technology, and data-led consumer insights, as well as its patent-pending revolutionary tools and technologies, new product development opportunities, and innovative team of experts.

Brandon Beatty, the longest-tenured CEO in the CBD industry and Founder and CEO of Bluebird Botanicals, said: “Bluebird has been an industry leader since its founding, and this acquisition further solidifies our position as a world-renowned hemp extract company that is committed to the highest standards of product quality and intently focused on human wellness. We believe the combination of Bluebird’s brand recognition and customer-centric approach with Precision’s science-driven model will lift both brands to new heights. We’re extremely proud and excited to partner with the scientists who founded Precision, as well as the talented and respected folks at Juggernaut Capital Partners.”

Since its founding in 2012, Bluebird, which is a Certified B Corporation, has focused strategically on its e-commerce operations and the natural and specialty sales channels. Consistent with this focus, the combination with Precision will serve to strengthen Bluebird’s presence in brick-and-mortar retail locations, as Precision has a fast-growing national footprint within convenience and grocery store channels.

In addition to the acquisition, Bluebird has received a growth investment from Juggernaut Capital Partners, a lower middle market private equity firm specializing in buyout and growth investments across the consumer and outsourced healthcare services industries. Juggernaut’s investment will strengthen the combined company’s financial profile and provide it with the resources to fuel further innovation in the CBD space, accelerate growth online, and assist future expansion into new channels.

For more information about this transaction, please contact:

James Cartales
Senior Vice President
(206) 436-2526

Or another senior member of Cascadia’s Food, Beverage & Agribusiness team:

Michael Butler
Chairman & CEO
(206) 436-2530

Erik Einwalter
Managing Director
(206) 436-2538

Bryan Jaffe
Managing Director
(206) 436-2534

Scott Porter
Managing Director
(206) 436-2528

George Sent
Managing Director
(206) 436-2511

Back to News